Epivir HBV

Epivir HBV

Epivir-HBV is used for treating certain types of chronic hepatitis B virus infection.
Product dosage: 100mg
Package (num)Per pillPriceBuy
301.77 $53.00 $ (0%)🛒 Add to cart
601.28 $106.00 $ 77.00 $ (27%)🛒 Add to cart
901.11 $159.00 $ 100.00 $ (37%)🛒 Add to cart
1201.03 $212.00 $ 124.00 $ (42%)🛒 Add to cart
1800.95 $318.00 $ 171.00 $ (46%)🛒 Add to cart
2700.89 $477.00 $ 241.00 $ (49%)🛒 Add to cart
360
0.86 $ Best per pill
636.00 $ 310.00 $ (51%)🛒 Add to cart
Synonyms

Epivir-HBV-–-Advanced-Antiviral-Therapy-for-Chroni

Epivir HBV (lamivudine) is a potent nucleoside analogue reverse transcriptase inhibitor (NRTI) specifically formulated for the treatment of chronic hepatitis B virus (HBV) infection. Clinically proven to suppress viral replication, Epivir HBV reduces liver inflammation and fibrosis, improving long-term patient outcomes. With high bioavailability and a well-tolerated safety profile, it is a trusted choice for healthcare providers worldwide.


Key Technical Specifications

  • Active Ingredient: Lamivudine (100 mg)
  • Dosage Form: Film-coated tablets
  • Pharmacokinetics:
    • Bioavailability: ~86%
    • Half-life: 5–7 hours
    • Metabolism: Minimal hepatic metabolism, primarily renal excretion
  • Storage Conditions: Store below 30°C (86°F), protect from moisture
  • Manufacturer: GlaxoSmithKline (GSK)
  • Regulatory Approvals: FDA, EMA, WHO prequalified

Why Choose Epivir HBV?

1. Clinically Proven Efficacy

  • Viral Load Reduction: Up to 4-log reduction in HBV DNA levels within 12 weeks.
  • ALT Normalization: Restores liver enzyme levels in >50% of patients.
  • HBeAg Seroconversion: Promotes immune clearance in ~20% of cases after 1 year.

2. Superior Safety Profile

  • Low Resistance Risk: Compared to older NRTIs.
  • Minimal Side Effects: Well-tolerated, with most adverse effects being mild (headache, fatigue).

3. Cost-Effective Treatment

  • Affordable: Priced competitively vs. newer HBV antivirals.
  • Generic Availability: Reduces healthcare costs without compromising efficacy.

4. Convenient Dosage

  • Once-Daily Regimen: Enhances patient compliance.

Epivir HBV Rating: ★★★★☆ (4.2/5)

AspectRating
Efficacy★★★★☆
Safety★★★★☆
Affordability★★★★★
Convenience★★★★☆

Pricing Comparison (30-Tablet Pack)

RegionPrice (USD)
USA$120–$150
Europe€90–€110
India (Generic)$25–$40
Canada$80–$100

(Prices may vary based on pharmacy and insurance coverage.)


Customer Testimonials

Dr. Alan K., Hepatologist (USA):
“Epivir HBV remains a first-line option for my HBV patients due to its reliability and cost-effectiveness. Resistance is manageable with proper monitoring.”

Patient Review (UK):
“After 6 months on Epivir HBV, my viral load dropped significantly. No side effects—highly recommend!”

Healthcare Provider (India):
“The generic version offers the same efficacy at a fraction of the cost. A game-changer in developing markets.”


Conclusion: A Trusted Solution for HBV Management

Epivir HBV combines proven efficacy, safety, and affordability, making it a cornerstone in chronic hepatitis B therapy. Whether as a standalone treatment or part of a combination regimen, it delivers consistent results with minimal complications.

Consult your healthcare provider today to see if Epivir HBV is right for you or your patients.

(Disclaimer: This product requires a prescription. Always follow medical advice.)

Key Takeaways for Buyers:

Effective HBV suppression
Low adverse event risk
Budget-friendly options available
Trusted by medical professionals

For bulk orders or institutional pricing, contact authorized distributors.